The Patent Finder

Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity

Amarin Pharma, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 16/702,236, filed Dec 3, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,712,428Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
In force
 · Medium confidence
Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland LimitedIn force
Medium confidence
US 11,712,429Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
In force
 · Medium confidence
Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland LimitedIn force
Medium confidence
Application 16/179,623Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
Abandoned
Abandoned May 2, 2022
Amarin Pharmaceuticals Ireland LimitedAbandonedAbandoned May 2, 2022
Application 16/702,236Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
Abandoned
Abandoned Mar 3, 2022
Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland LimitedAbandonedAbandoned Mar 3, 2022
Application 17/675,596Low Eructation Composition and Methods for Treating And/Or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
Abandoned
Abandoned Dec 4, 2024
Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland LimitedAbandonedAbandoned Dec 4, 2024
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Amarin Pharma, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited